AQP5 and colon carcinoma: By using siRNA to inhibit AQP5 activity in HT 29 colon carcinoma cell lines, the susceptibility of these populations to the chemotherapeutic agents cisplatin (DDP) and 5 fluorouracil (5 FU) was enhanced.